[Use of pre-mixed insulins in diabetes treatment of young patients].
The aim of the study was to analyse the administration of pre-mixed insulins in the young. We studied 46 type I (insulin-dependent) diabetic subjects aged from 2.5 to 9 years with diabetes duration from 1 to 10 years in a period of 3 years. 19 patients were treated with Novo Nordisk insulins and 27 patients with Lilly pre-mixed insulins during 10-38 months.


CONCLUSIONS
We suggest using pre-mixed insulins in diabetes of the young in: 1. A group of small children, where we resign from strict glycaemic control because of the risk of hypoglycaemia; 2. Patients with small insulin requirement and stabile diabetes, including diabetics in partial remission; 3. Patients who do not cooperate with diabetic team.
Jarosz-Chobot
P
P
Klinika Endokrynologii Dzieciecej Slaskiej AM w Katowicach.
Otto-Buczkowska
E
E
Malanowicz
B
B
Wiedermann
G
G